Scarlet raises $50M Series B for AI medical device certification push

Scarlet, a certification body for AI and software medical devices, has raised a $50 million Series B led by Headline, with participation from new investor Notion Capital and existing backers. The funding will accelerate the company’s certification programs for AI-driven diagnostics and monitoring tools.

The round follows a string of large AI-related funding announcements in recent weeks, including Flam’s $40 million Series B and VAST’s $446 million raise for 3D infrastructure. Unlike those companies, Scarlet operates in the regulatory compliance space, helping manufacturers navigate approval processes in key markets.

Demand for third-party certification has risen as regulators introduce stricter requirements for AI medical devices. Recent updates to regulatory frameworks have increased scrutiny on algorithmic transparency and post-market monitoring. Scarlet’s model—providing pre-submission reviews and continuous compliance support—positions it as a critical intermediary between developers and regulators.

The $50 million round is smaller than some recent AI infrastructure deals but reflects a growing niche. Investors appear to be betting on the need for specialized certification as the AI medical device pipeline expands. What remains unclear is whether Scarlet’s approach can scale beyond early adopters to become the default certification partner for the industry.

Sources: tech.eu